13 March 2023 | 18:00-19:30 | Permanent Representation of Austria to the European Union, Brussels
In March 2023, the European Commission is due to publish its proposal for the upcoming revision of the EU pharmaceutical legislation, to ensure a future-proof and crisis-resistant regulatory system. In this event key, experts will consider the opportunities and lessons learned from the pandemic and discuss how to ensure the security of access to and supply of medicines for all even in times of crisis, while fostering innovation and investment in research and striving for a new dialogue between public and private sector.
This event was organised in close cooperation with the Federal Ministry of Social Affairs, Health, Care and Consumer Protection, Austria and the Permanent Representation of Austria to the European Union.
Read the op-ed by EHFG President, Dr Clemens Martin Auer, on the subject here.
Federal Minister of Social Affairs, Health, Care and Consumer Protection, Austria
Deputy Prime Minister and Minister for Health, Malta
European Commissioner for Health and Food Safety
Executive Director, European Medicines Agency
Director, The European Consumer Organisation
Adrian van den Hoven
Director General, Medicines for Europe
Karla van Rooijen
Director of Pharmaceuticals and Medical Technology Department, Ministry of Health, Welfare and Sport, The Netherlands
Co-founder and managing director, Health Connect Partners